A Phase I Clinical Study on a New Oral Pentamidine Formulation in Hepatocellular Carcinoma
Clinical trial NCT02210182 · COMPLETED
Trial details
- NCT number
- NCT02210182
- Sponsor
- Oncozyme Pharma Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.